Document Detail


Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns.
MedLine Citation:
PMID:  7935986     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In our previous study we developed two lines of human larynx carcinoma HEp2 cells resistant to cis-diamminedichloroplatinum(II) (CDDP) due to acute (CA3 cells), or continuous (CK2 cells) treatments with increased CDDP concentrations. CA3 line was 2.3-fold resistant, and CK2 line 3.7-fold resistant to CDDP as compared to the parental cells. In this study the sensitivity of CDDP resistant and parental cells to several antitumor drugs was examined using clonogenic survival assay. CK2 cells were 1.7-fold more resistant to vincristine than parental cells, while CA3 cells exhibited resistance to vincristine only at higher concentrations of this drug. Verapamil, an inhibitor of P-glycoprotein, was not able to reverse the resistance of CK2 cells to vincristine, indicating that this cross-resistance did not involve P-glycoprotein. As compared to the parental cells, CK2 cells were 2.1-fold resistant, and CA3 cells 1.7-fold resistant to mitomycin C. CK2 cells were 2-fold more resistant to 5-fluorouracil than the parental cells, while CA3 cells did not exhibit any change in the sensitivity to this drug. CA3 cells were 0.4-fold sensitive to epoxide and 0.53-fold sensitive to doxorubicin, while CK2 cells had the same sensitivity to these drugs as the parental cells. Our results showed that treatment schedule determines the response of CDDP resistant human larynx carcinoma cells to additional drugs, suggesting the complexity of the judicious choice of the drugs in the combined modality treatments of cancer.
Authors:
L Beketić-Oresković; M Osmak
Related Documents :
1532346 - Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (hct-8) sublin...
12068086 - Specificity of resistance to oxidative stress.
3479586 - Effects of susceptibility of mares to endometritis and stage of cycle on phagocytic act...
15512946 - Effect of hydrostatic pressure gradients and na2edta on permeability of human schlemm's...
16382166 - Transdifferentiation in holothurian gut regeneration.
6259966 - Ultrastructural classification of paracrystalline inclusions in untreated and estrogen ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Neoplasma     Volume:  41     ISSN:  0028-2685     ISO Abbreviation:  Neoplasma     Publication Date:  1994  
Date Detail:
Created Date:  1994-11-17     Completed Date:  1994-11-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0377266     Medline TA:  Neoplasma     Country:  CZECH REPUBLIC    
Other Details:
Languages:  eng     Pagination:  171-6     Citation Subset:  IM    
Affiliation:
Ruder Bosković Institute, Zagreb, Croatia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
Cisplatin / pharmacology*
Drug Resistance
Drug Screening Assays, Antitumor
Etoposide / pharmacology
Humans
Laryngeal Neoplasms / drug therapy*
Mitomycin / pharmacology
Tumor Cells, Cultured / drug effects
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 15663-27-1/Cisplatin; 33419-42-0/Etoposide; 50-07-7/Mitomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in t...
Next Document:  Evaluation of chemopreventive effects of betel leaf on the genotoxicity of pan masala.